secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2022-02-17T23:59:59+00:00
Accession:  0001493152-22-004825
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic extends JV term sheet standstill with GMP to March 31, 2022
---------------------------------------------------------------------

- Extended standstill provisions of JV term sheet with Golden Mountain Partners to March 31, 2022.
- JV intended to develop Oncotelic's drug portfolio and build a manufacturing facility.
- Company previously announced plan to take the JV public via IPO at a future date.
- Extension allows additional time to complete the transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315222004825/0001493152-22-004825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315222004825/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-004825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer